AdvanSix Inc. (NYSE:ASIX - Get Free Report) SVP Achilles B. Kintiroglou sold 571 shares of the company's stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $23.65, for a total transaction of $13,504.15. Following the completion of the sale, the senior vice president now owns 32,555 shares of the company's stock, valued at $769,925.75. This represents a 1.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.
AdvanSix Stock Performance
AdvanSix stock traded up $0.28 on Friday, reaching $23.87. 116,422 shares of the stock were exchanged, compared to its average volume of 152,939. The stock has a market cap of $639.89 million, a PE ratio of 14.82 and a beta of 1.62. The company has a current ratio of 1.08, a quick ratio of 0.49 and a debt-to-equity ratio of 0.25. AdvanSix Inc. has a twelve month low of $18.44 and a twelve month high of $33.00. The firm has a fifty day moving average price of $22.10 and a two-hundred day moving average price of $26.34.
AdvanSix Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 2.68%. The ex-dividend date of this dividend was Tuesday, May 13th. AdvanSix's dividend payout ratio is 20.51%.
Analyst Upgrades and Downgrades
A number of research firms have weighed in on ASIX. UBS Group set a $35.00 target price on shares of AdvanSix in a research report on Tuesday, March 18th. Wall Street Zen raised shares of AdvanSix from a "buy" rating to a "strong-buy" rating in a research report on Saturday, May 31st. Finally, Piper Sandler set a $32.00 target price on shares of AdvanSix in a research report on Monday, May 19th.
Get Our Latest Report on AdvanSix
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of the company. Victory Capital Management Inc. raised its position in shares of AdvanSix by 0.6% during the first quarter. Victory Capital Management Inc. now owns 2,407,512 shares of the company's stock valued at $54,530,000 after buying an additional 15,367 shares during the last quarter. Vanguard Group Inc. raised its position in shares of AdvanSix by 1.5% during the first quarter. Vanguard Group Inc. now owns 1,981,063 shares of the company's stock valued at $44,871,000 after buying an additional 29,963 shares during the last quarter. Dimensional Fund Advisors LP raised its position in shares of AdvanSix by 0.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,578,908 shares of the company's stock valued at $44,982,000 after buying an additional 12,793 shares during the last quarter. American Century Companies Inc. raised its position in shares of AdvanSix by 11.3% during the first quarter. American Century Companies Inc. now owns 823,706 shares of the company's stock valued at $18,657,000 after buying an additional 83,678 shares during the last quarter. Finally, Wellington Management Group LLP raised its position in shares of AdvanSix by 5.7% during the first quarter. Wellington Management Group LLP now owns 712,431 shares of the company's stock valued at $16,137,000 after buying an additional 38,546 shares during the last quarter. Institutional investors and hedge funds own 86.39% of the company's stock.
About AdvanSix
(
Get Free Report)
AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.
See Also
Before you consider AdvanSix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdvanSix wasn't on the list.
While AdvanSix currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
